Physician profile
Sunavo Dasgupta
NPI 1750442422
$2,191.84
in general payments reported to CMS, 2019-2025
23 companies · $390 in 2025
The $390 reported for 2025 was less than what a typical Pain Medicine (Anesthesiology) provider received nationally (typical 2025 total: $458).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $691 · 2020: $173 · 2023: $356 · 2024: $581 · 2025: $390.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,328.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,327.69 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $1,258.94 | 2019-2025 | Proclaim, Eterna |
| Lilly USA, LLC | $166.47 | 2019-2020 | |
| Collegium Pharmaceutical, INC. | $117.40 | 2019-2020 | |
| Boston Scientific Corporation | $101.71 | 2019-2020 | |
| Teva Pharmaceuticals USA, INC. | $65.48 | 2019 | |
| Nevro Corp. | $57.57 | 2019 | |
| Abbvie INC. | $53.61 | 2025 | |
| Scilex Pharmaceuticals INC. | $42.58 | 2019 | |
| Allergan, INC. | $40.86 | 2020 | |
| Pacira Therapeutics, INC. | $34.00 | 2019-2020 | |
| Fidia Pharma USA INC. | $29.06 | 2020 | |
| Medtronic USA, INC. | $25.61 | 2019 | |
| Si-Bone, INC. | $24.84 | 2019 | |
| Arbor Pharmaceuticals, INC. | $24.56 | 2019 | |
| Pacira Pharmaceuticals Incorporated | $24.31 | 2024 | Iovera |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertos Medical, INC. | $20.73 | 2023 | Mild Device Kit |
| Vertiflex, INC. | $17.18 | 2019 | |
| Depuy Synthes Sales INC. | $16.54 | 2023 | Orthovisc, Monovisc |
| Mdd US Operations, LLC | $16.39 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $16.15 | 2019 | |
| Pfizer INC. | $14.29 | 2019 | |
| Zyla Life Sciences, INC. | $12.29 | 2020 | |
| Assertio Therapeutics, INC. | $11.27 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Sunavo Dasgupta listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.